Comparing the Effects of Spironolactone With Chlortalidone on LV Mass and Arterial Stiffness in Patients With CKD
|2||Active, not recruiting||
Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT
PIE II: Pharmacological Intervention in the Elderly II
† Indicates status has not been verified in more than two years